Showing chemical card for 2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid (CFc000148177)
2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid belongs to the class of organic compounds known as withanolides and derivatives. These are c28 steroids structurally characterized by an ergostane skeleton usually functionalized at carbons 1, 22 and 26 to form a lactone ring. Based on a literature review very few articles have been published on 2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid.
MOL for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
3D MOL for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
3D SDF for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
3D-SDF for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
PDB for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
3D PDB for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
SMILES for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
INCHI for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
Structure for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
3D Structure for CFc000148177 (2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-({14-[1-(4,5-dimethyl-6-oxooxan-2-yl)-1-hydroxyethyl]-7,8-dihydroxy-2,15-dimethyl-3-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-4-en-9-yl}sulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid)
Belongs to the class of organic compounds known as withanolides and derivatives. These are c28 steroids structurally characterized by an ergostane skeleton usually functionalized at carbons 1, 22 and 26 to form a lactone ring.